Information Provided By:
Fly News Breaks for May 12, 2017
DGX
May 12, 2017 | 09:21 EDT
Craig-Hallum analyst Kevin Ellich raised his price target for Quest Diagnostics to $106 from $86 reflecting a higher target multiple given the stability of the business. The analyst has an improved outlook for Quest based on solid Q1 results and strong free cash flow generation, however he thinks this is already priced into its valuation. Ellich reiterates a Hold rating on the shares.
News For DGX From the Last 2 Days
There are no results for your query DGX